Study of ONO-2506 in Patients With Acute Ischemic Stroke

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

757

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Stroke
Interventions
DRUG

ONO-2506

Once daily one-hour intravenous infusion at 12/mg/kg/hr for 7 days

DRUG

ONO-2506

Once daily one-hour intravenous infusion at 0 mg/kg/hr for 7 days

DRUG

ONO-2506

Once daily one-hour intravenous infusion at 8 mg/kg/hr for 7 days

Trial Locations (9)

Unknown

Chugoku Region Facility, Chugoku

Chubu Region Facility, Chūbu

Hokkaido Region Facility, Hokkaido

Hokuriku Region Facility, Hokuriku

Kanto Region Facility, Kanto

Kinki Region Facility, Kinki

Kyushu Region Facility, Kyushu

Shikoku Region Facility, Shikoku

Tohoku Region Facility, Tohuku

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY